Definition of Post-Marketing Phase III Clinical Trial (hereinafter referred to as the Clinical Trial

  1. Post-Marketing Phase III Clinical Trial (hereinafter referred to as the Clinical Trial means a Phase III efficacy trial conducted according to a protocol as agreed upon between the Parties and the Swedish regulatory authorities in high-risk melanoma patients in the EU, and funded according to Exhibit 1.

Definition of Post-Marketing Phase III Clinical Trial (hereinafter referred to as the Clinical Trial in License Agreement

Post-Marketing Phase III Clinical Trial (hereinafter referred to as the Clinical Trial means a Phase III efficacy trial conducted according to a protocol as agreed upon between the Parties and the Swedish regulatory authorities in high-risk melanoma patients in the EU, and funded according to Exhibit 1.